The Emergent Landscape of Detecting EGFR Mutations Using Circulating Tumor DNA in Lung Cancer

The advances in targeted therapies for lung cancer are based on the evaluation of specific gene mutations especially the epidermal growth factor receptor (EGFR). The assays largely depend on the acquisition of tumor tissue via biopsy before the initiation of therapy or after the onset of acquired re...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Wei-Lun, Wei, Fang, Wong, David T., Lin, Chien-Chung, Su, Wu-Chou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584057/
https://www.ncbi.nlm.nih.gov/pubmed/26448936
http://dx.doi.org/10.1155/2015/340732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584057/
https://www.ncbi.nlm.nih.gov/pubmed/26448936
http://dx.doi.org/10.1155/2015/340732

Ejemplares similares